Form 4: Colgate-Palmolive CEO's Planned Tax Withholding

Colgate-Palmolive Chairman, President & CEO Noel R. Wallace reported a planned disposition of 1,307 common shares for tax obligations on December 3, 2025.

Summary

• Noel R. Wallace, Chairman, President & CEO, and Director of Colgate-Palmolive Co. (CL), reported a planned transaction.
• On December 3, 2025, 1,307 shares of common stock were disposed of at a price of $78.2 per share.
• This disposition was for the payment of Medicare and income tax liability, executed by withholding shares from previously granted restricted stock units.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating it was pre-scheduled.
• Following this transaction, Wallace will directly own 338,756 shares and indirectly own 53,923 shares via the Issuer's 401(k) Plan Trustee, 52,000 shares via a Spouse Trust, and 335 shares via another Trust.

Sentiment

Score: 5

Explanation: The transaction is a neutral, routine tax withholding related to executive compensation, with no significant positive or negative implications for the company's operations or financial health.

Positives

• The transaction is a routine tax withholding, indicating the vesting of previously granted restricted stock units, which is a form of executive compensation.
• The disposition was made pursuant to a Rule 10b5-1 plan, demonstrating pre-planned and transparent management of equity compensation.

Negatives

• The disposition of shares, while for tax purposes, slightly reduces the direct equity holdings of the CEO.

Future Outlook

The filing does not contain specific forward-looking statements or guidance beyond the planned transaction date.

Industry Context

This transaction is a routine insider filing related to executive compensation and tax obligations, common across all publicly traded companies. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as it's a routine tax withholding. It confirms executive compensation structures are functioning as expected.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned tax withholding by the CEO related to vested restricted stock units. Such transactions are common for executive compensation and do not typically signal any change in the company's fundamentals or management's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is maintained based on the neutrality of this specific filing.

Keywords

Colgate-Palmolive, CL, Noel R. Wallace, Form 4, SEC Filing, Insider Transaction, Tax Withholding, Restricted Stock Units, Executive Compensation, Rule 10b5-1